TGFB1 and inflammatory bowel disease: Although the significance of these findings is unknown at the present time, our laboratory is actively investigating the effects of genetic manipulation of TGFβ and IL-6, as well as their pharmacological blockade, in SAMP mice to precisely determine the role of these cytokines in experimental IBD and CAC.